MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults

Agin-Liebes, GI, Malone, T, Yalch, MM, et al. (2020) Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology (Oxford, England) 34(2): 155–166.
Google Scholar | SAGE Journals | ISI American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders : DSM-IV. Washington, DC.
Google Scholar Baumeister, D, Barnes, G, Giaroli, G, et al. (2014) Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Therapeutic Advances in Psychopharmacology 4(4): 156–169.
Google Scholar | SAGE Journals Bentley, KH, Franklin, JC, Ribeiro, JD, et al. (2016) Anxiety and its disorders as risk factors for suicidal thoughts and behaviors: A meta-analytic review. Clinical Psychology Review 43: 30–46.
Google Scholar | Crossref | Medline Bogenschutz, MP, Johnson, MW (2016) Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64: 250–258.
Google Scholar | Crossref | Medline | ISI Bogenschutz, MP, Forcehimes, AA, Pommy, JA, et al. (2015) Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29(3): 289–299.
Google Scholar | SAGE Journals | ISI Bohnert, KM, Ilgen, MA, Louzon, S, et al. (2017) Substance use disorders and the risk of suicide mortality among men and women in the US veterans health administration. Addiction 112(7): 1193–1201.
Google Scholar | Crossref | Medline Clemens, KJ, McGregor, IS, Hunt, GE, et al. (2007) MDMA, methamphetamine and their combination: Possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review 26(1): 9–15.
Google Scholar | Crossref | Medline Cole, JC, Bailey, M, Sumnall, HR, et al. (2002) The content of ecstasy tablets: Implications for the study of their long-term effects. Addiction 97(12): 1531–1536.
Google Scholar | Crossref | Medline Cougle, JR, Keough, ME, Riccardi, CJ, et al. (2009) Anxiety disorders and suicidality in the national comorbidity survey-replication. Journal of Psychiatric Research 43(9): 825–829.
Google Scholar | Crossref | Medline | ISI Danforth, AL, Grob, CS, Struble, C, et al. (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235(11): 3137–3148.
Google Scholar | Crossref | Medline Davison, D, Parrott, AC (1997) Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects. Human Psychopharmacology: Clinical and Experimental 12(3): 221–226.
Google Scholar | Crossref Doblin, R, Greer, G, Holland, J, et al. (2014) A reconsideration and response to Parrott AC (2013) “human psychobiology of MDMA or ‘ecstasy’: An overview of 25 years of empirical research.” Human Psychopharmacology: Clinical and Experimental 29(2): 105–108.
Google Scholar | Crossref | Medline Dwivedi, Y (2010) Brain-derived neurotrophic factor and suicide pathogenesis. Annals of Medicine 42(2): 87–96.
Google Scholar | Crossref | Medline | ISI Dwivedi, Y, Rizavi, HS, Conley, RR, et al. (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 60(8): 804–815.
Google Scholar | Crossref | Medline Dyck, E (2015) LSD: A new treatment emerging from the past. CMAJ : Canadian Medical Association Journal = Journal De L’association Medicale Canadienne 187(14): 1079–1080.
Google Scholar | Crossref Farré, M, Abanades, S, Roset, PN, et al. (2007) Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: Pharmacological effects and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 323(3): 954–962.
Google Scholar | Crossref | Medline Flanagan, TW, Nichols, CD (2018) Psychedelics as anti-inflammatory agents. International Review of Psychiatry 30(4): 363–375.
Google Scholar | Crossref | Medline Gasser, P, Holstein, D, Michel, Y, et al. (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. The Journal of Nervous and Mental Disease 202(7): 513–520.
Google Scholar | Crossref | Medline | ISI Gaynes, BN, West, SL, Ford, CA, et al. (2004) Screening for suicide risk in adults: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 140(10): 822–835.
Google Scholar | Crossref | Medline | ISI Gorska, AM, Kamińska, K, Wawrzczak-Bargieła, A, et al. (2018) Neurochemical and neurotoxic effects of MDMA (ecstasy) and caffeine after chronic combined administration in mice. Neurotoxicity Research 33(3): 532–548.
Google Scholar | Crossref | Medline Greer, G, Tolbert, R (1986) Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs 18(4): 319–327.
Google Scholar | Crossref | Medline Greer, GR, Tolbert, R (1998) A method of conducting therapeutic sessions with MDMA. Journal of Psychoactive Drugs 30(4): 371–379.
Google Scholar | Crossref | Medline | ISI Griffiths, RR, Johnson, MW, Carducci, MA, et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England) 30(12): 1181–1197.
Google Scholar | SAGE Journals | ISI Griffiths, RR, Richards, WA, McCann, U, et al. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187(3): 268–283.
Google Scholar | Crossref | Medline | ISI Grob, CS, Danforth, AL, Chopra, GS, et al. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry 68(1): 71–78.
Google Scholar | Crossref | Medline Harris, EC, Barraclough, B (1997) Suicide as an outcome for mental disorders: A meta-analysis. British Journal of Psychiatry 170(3): 205–228.
Google Scholar | Crossref | Medline | ISI Hedegaard, H, Curtin, SC, Warner, M (2018a) Suicide mortality in the United States, 1999–2017. NCHS Data Brief (330): 1–8.
Google Scholar Hedegaard, H, Curtin, SC, Warner, M (2018b) Suicide rates in the United States continue to increase. NCHS Data Brief (330): 1–8.
Google Scholar Hedegaard, H, Curtin, SC, Warner, M (2020) Increase in Suicide Mortality in the United States, 1999–2018 NCHS Data Brief (362): 1–8.
Google Scholar | Crossref Hendricks, PS, Crawford, MS, Cropsey, KL, et al. (2018) The relationships of classic psychedelic use with criminal behavior in the United States adult population. Journal of Psychopharmacology 32(1): 37–48.
Google Scholar | SAGE Journals | ISI Hendricks, PS, Johnson, MW, Griffiths, RR (2015a) Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology (Oxford, England) 29(9): 1041–1043.
Google Scholar | SAGE Journals | ISI Hendricks, PS, Thorne, CB, Clark, CB, et al. (2015b) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology 29(3): 280–288.
Google Scholar | SAGE Journals | ISI Hill, AB (1965) The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 58(5): 295–300.
Google Scholar | SAGE Journals Holland, J (2001) Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits of MDMA. Rochester, VT: Park Street Press.
Google Scholar Hysek, CM, Schmid, Y, Simmler, LD, et al. (2014) MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience 9(11): 1645–1652.
Google Scholar | Crossref | Medline Inagaki, M, Kawashima, Y, Kawanishi, C, et al. (2015) Interventions to prevent repeat suicidal behavior in patients admitted to an emergency department for a suicide attempt: A meta-analysis. Journal of Affective Disorders 175: 66–78.
Google Scholar | Crossref | Medline Johnson, MW, Griffiths, RR (2017) Potential therapeutic effects of psilocybin. Neurotherapeutics 14(3): 734–740.
Google Scholar | Crossref | Medline Johnson, MW, Garcia-Romeu, A, Cosimano, MP, et al. (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England) 28(11): 983–992.
Google Scholar | SAGE Journals | ISI Jones, T, Baxter, M, Khanduja, V (2013) A quick guide to survey research. Annals of the Royal College of Surgeons of England 95(1): 5–7.
Google Scholar | Crossref | Medline Kamilar-Britt, P, Bedi, G (2015) The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. Neuroscience and Biobehavioral Reviews 57: 433–446.
Google Scholar | Crossref | Medline | ISI Kessler, RC, Bromet, EJ (2013) The epidemiology of depression across cultures. Annual Review of Public Health 34: 119–138.
Google Scholar | Crossref | Medline | ISI Kessler, RC, Berglund, P, Borges, G, et al. (2005) Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA : The Journal of the American Medical Association 293(20): 2487–2495.
Google Scholar | Crossref | Medline | ISI Kothgassner, OD, Robinson, K, Goreis, A, et al. (2020) Does treatment method matter? A meta-analysis of the past 20 years of research on therapeutic interventions for self-harm and suicidal ideation in adolescents. Borderline Personality Disorder and Emotion Dysregulation 7(1): 9.
Google Scholar | Crossref | Medline Krebs, TS, Johansen, P-Ø (2013) Psychedelics and mental health: A population study. PLoS ONE 8(8): e63972.
Google Scholar | Crossref | Medline | ISI Liechti, ME, Gamma, A, Vollenweider, FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154(2): 161–168.
Google Scholar | Crossref | Medline Lumley, T (2020) Survey: Analysis of complex survey samples. R package version 4.0. Available at: https://CRAN.R-project.org/package=survey (accessed 24 September 2020).
Google Scholar Ly, C, Greb, AC, Cameron, LP, et al. (2018) Psychedelics promote structural and functional neural plasticity. Cell Reports 23(11): 3170–3182.
Google Scholar | Crossref | Medline Mahapatra, A, Gupta, R (2017) Role of psilocybin in the treatment of depression. Therapeutic Advances in Psychopharmacology 7(1): 54–56.
Google Scholar | SAGE Journals | ISI Mitchell, JM, Bogenschutz, M, Lilienstein, A, et al. (2021) MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine 27: 1025–1033.
Google Scholar | Crossref | Medline Mithoefer, MC, Feduccia, AA, Jerome, L, et al. (2019) MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236(9): 2735–2745.

留言 (0)

沒有登入
gif